Drew Quality's goal is to produce generic prescriptions at a fair price, and they are doing so as a nonprofit; finding foundations to support their work has not been easy.
"It’s a long way from Manhattan, where Turing Pharmaceuticals this fall raised the price of a generic drug to fight parasitic infections by 5,000 percent. The aim, in the words of founder Martin Shkreli, was “to make as much money as possible.”
"But in this Central Massachusetts town, a small team of drug industry veterans has launched a startup to counter Turing and other biopharma price gougers by making affordable generic medicines to treat critical diseases. And they’re doing it as a nonprofit."--Robert Weisman, The Boston Globe
